ArticlePediatric research2026
The effect of inhaled nitric oxide on splanchnic perfusion in a neonatal piglet model.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInhaled nitric oxide (iNO) is a commonly used pulmonary vasodilator in neonates, but its effects on intestinal perfusion remain unclear. This study assessed the impact of iNO on splanchnic tissue oxygenation as a surrogate for intestinal perfusion using near infrared spectroscopy (NIRS), with NG-nitro-L-arginine methyl ester (L-NAME) used to inhibit endogenous nitric oxide synthase (NOS) and isolate the effect of exogenous NO.
methodsSeventeen piglets (7-10 days old) were anesthetized and ventilated with NIRS probes placed on the forehead and abdomen. Piglets were allocated to group 1 (n = 4) receiving iNO only, group 2 (n = 6) receiving iNO then L-NAME, and group 3 (n = 7) receiving L-NAME then iNO. Serum nitrate/nitrite and endothelin-1 expression were assessed via colorimetric assay and ELISA.
resultsiNO increased splanchnic oxygenation, significantly reducing the difference between cerebral and abdominal NIRS. This effect was blunted by L-NAME pre-treatment (p = 0.02 at 0 and 60 ppm). Serum nitrate/nitrite and endothelin-1 levels did not differ significantly between groups, nor did mean arterial pressure.
conclusioniNO enhances splanchnic tissue oxygenation to near cerebral levels. Pretreatment with L-NAME eliminates this effect, suggesting a role for endogenous NOS in this process. These findings suggest a potential protective role of iNO against intestinal ischemia and merit further investigation. IMPACT: As shown in previous studies, there are extrapulmonary effects of inhaled nitric oxide (iNO) on tissue perfusion; this study specifically validates this by evaluating oxygenation of the gut. iNO increases splanchnic tissue oxygenation to cerebral levels. This preclinical research establishes improvement in intestinal oxygenation with iNO use in contrast to other studies proposing iNO as a potential contributor to the development of NEC in the setting of cardiac defects. This study suggests that iNO could be a potential therapeutic agent in ischemic intestinal conditions.
Identifiers
41813981What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.